Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo

Ítems similars

• The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
  per: Shi, Fei, et al.
  Publicat: (2017)
• Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells
  per: Sunayama, Jun, et al.
  Publicat: (2010)
• A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
  per: Wise-Draper, Trisha M., et al.
  Publicat: (2017)
• Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
  per: Xianbo Wu, et al.
  Publicat: (2022-05-01)
• Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
  per: Bhatt, Aadra P., et al.
  Publicat: (2010)